In AMD, EGCG reduces VEGFA expression and downregulates the HIF-1α/VEGF/VEGFR2 pathway, preventing choroidal neovascularization and limiting vision loss [81]. The gene discussed is VEGFA; the disease is age-related macular degeneration.